Description:
Kalorama Information is proud to announce a comprehensive new market research report, offering an in-depth overview of the In Vitro Diagnostics (IVD) market in India. This report delves into the IVD discipline, covering reagents, consumables, calibrators, and controls across various sub-segments, providing a detailed analysis of market trends and influences.
Report Highlights:
- Clinical Chemistry: Includes routine lab testing such as substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC), as well as urinalysis and blood chemistry testing.
- Immunoassays: Covers a range of tests including hormones and thyroid function, tumor markers, allergy, anemia, neonatal and prenatal tests, interleukins, PCT, toxicology, and common infectious diseases like HIV, hepatitis, and influenza.
- Microbiology and Molecular Testing: Features manual and automated tests, culture media, latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, and nucleic acid testing.
- Point-of-Care Testing: Includes all POC tests for cardiology, toxicology, coagulation, diabetes, and infectious diseases, along with POC and non-POC blood gas and electrolytes, and glucose self-monitoring tests.
- Histology/Cytology: Encompasses PAP, HE, IHC, ISH, FISH, and primary and secondary antibodies.
The report also includes an analysis of trends influencing the industry, backed by country-level data on disease incidence, life expectancy, population demographics, economic status, healthcare utilization, and other market drivers.
Market Data:
- Focused on the Indian IVD market at the manufacturers’ level.
- Market data for the year 2021, with forecast data extending to 2026.
- Compound annual growth rates (CAGRs) provided for the 2021-2026 period.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: India In Vitro Diagnostic Sales, by Extracted Market Segment, 2021-2026 (in millions $)
| Segment | Sales $ 2021 |
Sales $ 2026 |
CAGR |
| General Chemistry | $XX Million | $XX Million | XX% |
| Blood Gas Analysis | $XX Million | $XX Million | XX% |
| Urinalysis | $XX Million | $XX Million | XX% |
| Infectious Disease Immunoassays | $XX Million | $XX Million | XX% |
| Other Immunoassays | $XX Million | $XX Million | XX% |
| Blood Bank Screening Immunoassays | $XX Million | $XX Million | XX% |
| POC Glucose | $XX Million | $XX Million | XX% |
| POC Other | $XX Million | $XX Million | XX% |
| ID/AST | $XX Million | $XX Million | XX% |
| Microbiology Molecular | $XX Million | $XX Million | XX% |
| HPV | $XX Million | $XX Million | XX% |
| CTC | $XX Million | $XX Million | XX% |
| Other Histology | $XX Million | $XX Million | XX% |
| Others | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | XX% |
Source: Kalorama Information
